Relaxis, a vibratory counterstimulation device for restless legs syndrome patients that was US Food and Drug Administration cleared in 2014, is no longer filling new prescriptions.

[RELATED: Non-Pharmacologic Interventions for Restless Legs Syndrome Management]

According to the device’s website, “Rather than providing coverage for this important technology, CMS [the Centers for Medicare and Medicaid Services] has classified Relaxis as a ‘pleasure device.’ According to CMS, anything that vibrates is a ‘pleasure device,’ and as such, is not eligible for coverage….Due to CMS’ decision, it is no longer feasible to continue offering Relaxis.”